X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (72) 72
Book Review (6) 6
Conference Proceeding (2) 2
Publication (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (50) 50
humans (47) 47
female (40) 40
adolescent (35) 35
adult (33) 33
human papillomavirus (23) 23
vaccines (23) 23
young adult (23) 23
papillomavirus infections - prevention & control (21) 21
cervical cancer (19) 19
clinical trials (17) 17
double-blind method (16) 16
immunology (16) 16
vaccination (16) 16
immunization (15) 15
infectious diseases (15) 15
papillomavirus infections (15) 15
papillomavirus infections - epidemiology (15) 15
particle vaccine (15) 15
research (14) 14
risk factors (14) 14
abridged index medicus (13) 13
male (13) 13
young-women (13) 13
cervical intraepithelial neoplasia (12) 12
efficacy (12) 12
quadrivalent vaccine (12) 12
human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18 (11) 11
united-states (11) 11
cancer (10) 10
middle aged (10) 10
papillomavirus infections - virology (10) 10
papillomavirus vaccines - administration & dosage (10) 10
prevention (10) 10
uterine cervical neoplasms - prevention & control (10) 10
uterine cervical neoplasms - virology (10) 10
women (10) 10
cervical intraepithelial neoplasia - virology (9) 9
infection (9) 9
pediatrics (9) 9
vaccine (9) 9
disease (8) 8
oncology (8) 8
risk (8) 8
uterine cervical neoplasms - epidemiology (8) 8
clinical-trials (7) 7
follow-up studies (7) 7
genital warts (7) 7
genotype (7) 7
hpv (7) 7
immunogenicity (7) 7
medicine, general & internal (7) 7
papillomavirus vaccines - adverse effects (7) 7
papillomavirus vaccines - therapeutic use (7) 7
papillomaviruses (7) 7
pneumococcal conjugate vaccine (7) 7
randomized controlled trials as topic (7) 7
randomized controlled-trial (7) 7
adolescents (6) 6
antibodies (6) 6
cervical intraepithelial neoplasia - prevention & control (6) 6
cervical-cancer (6) 6
child (6) 6
cost-effectiveness (6) 6
hpv vaccine (6) 6
infections (6) 6
internal medicine (6) 6
intraepithelial neoplasia (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
medicine, research & experimental (6) 6
neutralizing epitopes (6) 6
papillomavirus vaccines (6) 6
placebos (6) 6
prevalence (6) 6
public health (6) 6
sexual behavior (6) 6
studies (6) 6
time factors (6) 6
treatment outcome (6) 6
warts (6) 6
cervical intraepithelial neoplasia - epidemiology (5) 5
clinical medicine (5) 5
grade cervical lesions (5) 5
health aspects (5) 5
hpv infection (5) 5
incidence (5) 5
klinisk medicin (5) 5
medical colleges (5) 5
medicine & public health (5) 5
natural-history (5) 5
papillomaviridae - immunology (5) 5
papillomavirus infections - complications (5) 5
papillomavirus vaccines - immunology (5) 5
pneumonia (5) 5
polymerase chain reaction (5) 5
proline - analogs & derivatives (5) 5
public, environmental & occupational health (5) 5
squamous-cell carcinoma (5) 5
virus-like particles (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Infectious Diseases, ISSN 1473-3099, 07/2019, Volume 19, Issue 7, pp. 692 - 693
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 40, pp. 5406 - 5417
Abstract Streptococcus pneumoniae is a frequent cause of community acquired pneumonia (CAP), with the largest burden of disease attributed to non-bacteremic... 
Allergy and Immunology | Pneumococcal conjugate vaccine | Invasive pneumococcal disease | Community-acquired pneumonia | Streptococcus pneumoniae | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS | OLDER-ADULTS | IMMUNOLOGY | HIV-INFECTED PATIENTS | CHRONIC LUNG-DISEASE | ELDERLY PERSONS | POPULATION-BASED COHORT | CLINICAL EFFECTIVENESS | POLYSACCHARIDE VACCINE | Pneumonia, Pneumococcal - immunology | Humans | Pneumococcal Vaccines - therapeutic use | Polysaccharides, Bacterial - immunology | Streptococcus pneumoniae - immunology | Vaccines, Conjugate - immunology | Pneumococcal Infections - immunology | Streptococcus pneumoniae - pathogenicity | Vaccination - methods | Vaccines, Conjugate - therapeutic use | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Adult | Pneumonia, Pneumococcal - prevention & control | Community-Acquired Infections - prevention & control | Community-Acquired Infections - immunology | Usage | Adults | Vaccines | B cells | Pneumonia, Pneumococcal | Drug approval | Medical research | Vaccination | T cells | Prevention | Health maintenance organizations | Medicine, Experimental | Aged | Microbial polysaccharides | Enzyme-linked immunosorbent assay | Public health | Elderly people | Pneumonia | Antibodies | Lymphocytes T | Streptococcus infections | Polysaccharides | Lymphocytes | Older people | Bacteria | Saccharides | Age | Antigens | Capsular polysaccharides | Immunization | Memory cells | Immune response | Effectiveness | Disease prevention | Immune systems | Studies | Immunogenicity | Lymphocytes B | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1207 - 1217
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2009, Volume 199, Issue 6, pp. 805 - 814
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 10/2010, Volume 102, Issue 19, pp. 1517 - 1518
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Women | Studies | Human papillomavirus | Immunization | Teenagers | Vaccines | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Cancer Epidemiology, ISSN 1877-7821, 2012, Volume 36, Issue 3, pp. e183 - e189
Abstract Introduction : Risk for HPV6/11/16/18 infections in young sexually active, behaviorally low-risk females is not well described and may inform public... 
Hematology, Oncology and Palliative Medicine | Internal Medicine | Trichomonas and HPV | HPV-serology | Chlamydia and HPV | Cervicovaginal infections | Bacterial vaginosis and HPV | HPV behavioral risk factors | HPV-DNA detection | HPV-infection | UNITED-STATES | CONTROLLED-TRIAL | COST-EFFECTIVENESS | CHLAMYDIA-TRACHOMATIS | SEXUAL-BEHAVIOR | CERVICAL INTRAEPITHELIAL NEOPLASIA | QUADRIVALENT VACCINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ONCOLOGY | PARTICLE VACCINE | YOUNG-WOMEN | HUMAN-PAPILLOMAVIRUS INFECTION | Humans | Papillomavirus Infections - epidemiology | Risk Factors | Human papillomavirus 6 - genetics | Sexual Behavior - statistics & numerical data | Human papillomavirus 6 - isolation & purification | Genotype | Alcohol Drinking | Human papillomavirus 11 - genetics | Young Adult | Human papillomavirus 16 - isolation & purification | Human papillomavirus 18 - isolation & purification | Sexually Transmitted Diseases | Risk-Taking | Adolescent | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - immunology | Human papillomavirus 18 - genetics | Human papillomavirus 11 - isolation & purification | Human papillomavirus 16 - genetics | Papillomavirus Vaccines - administration & dosage | Immunization | Young adults | Yeast | Stock options | Clinical trials | Gonorrhea | Cost control | Human papillomavirus | Licensed products | Behavior | Genetic testing | Cervical cancer | Deoxyribonucleic acid--DNA | Index Medicus | Dysplasia | Demography | Ethanol | Risk groups | Vaccination | Sex | Sexual behavior | Antibodies | Menarche | Data processing | Serology | Vaccines | Public policy | Risk factors | Vaginosis | Infection | Genotyping | Trichomoniasis | DNA | Sexual partners
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2005, Volume 6, Issue 5, pp. 271 - 278
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 19, pp. 1928 - 1943
Journal Article
Pediatrics, ISSN 0031-4005, 09/2014, Volume 134, Issue 3, pp. e657 - e665
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 19, pp. 1915 - 1927
In this large, randomized, placebo-controlled trial, a quadrivalent vaccine (including human papillomavirus types 6, 11, 16 and 18) given at day 1, month 2,... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | CYTOLOGY INTERPRETATIONS | FOLLOW-UP | INFECTION | RANDOMIZED CONTROLLED-TRIAL | INTRAEPITHELIAL NEOPLASIA | YOUNG-WOMEN | SUSTAINED EFFICACY | HPV TYPES | Double-Blind Method | Follow-Up Studies | Humans | Uterine Cervical Neoplasms - epidemiology | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Alphapapillomavirus | DNA, Viral - blood | Human papillomavirus 16 - isolation & purification | Human papillomavirus 18 - isolation & purification | Adenocarcinoma - prevention & control | Time Factors | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Papillomavirus Vaccines - adverse effects | Adult | Female | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 18 - genetics | Adenocarcinoma - epidemiology | Human papillomavirus 16 - genetics | Prevention | Cervical cancer | Disease prevention | Clinical trials | Human papillomavirus | Clinical outcomes | Index Medicus | Abridged Index Medicus | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Mikrobiologi inom det medicinska området | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article